Scholarlink

<p>Ureteropelvic junction obstruction (UPJO) is a common cause of hydronephrosis in children. We aimed to investigate the efficacy of robotic-assisted laparoscopic pyeloplasty (RALP) in newborns with UPJO compared to laparoscopic pyeloplasty (LP). We conducted a retrospective study of newborns aged ≤ 3 months who underwent RALP or LP from May 2018 to December 2023. Only primary pyeloplasty cases were included. Seventy-seven newborns (RALP = 46; LP = 31) were enrolled and no significant difference in the newborns’ demographics and pre-operative parameters was found. The mean operation time (OT) was 161.30 ± 29.07&#xa0;min (RALP) and 200.60 ± 26.66&#xa0;min (LP) (P &lt; 0.0001), and the mean hospitalization stay was 7.80 ± 1.13 days (RALP) and 9.32 ± 1.19 days (LP) (P &lt; 0.0001). RALP was associated with a higher hospitalization cost than LP (73449 ± 8513 yuan vs. 40152 ± 7555 yuan; P &lt; 0.0001). The effectiveness and safety of RALP for treating UPJO in newborns is comparable to that of LP. In addition, RALP might have advantages over LP with its faster recovery and less trauma. </p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Da Vinci robotic assisted pyeloplasty versus laparoscopic pyeloplasty in newborns under 3 months

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月4日

查看全文
  • Boshen Shu,
  • Shufeng Zhang,
  • Jian Gao,
  • Lin Wang,
  • Shuangshuang Wang,
  • Ruoyi Shi,
  • Xiaohui Wang

摘要

Ureteropelvic junction obstruction (UPJO) is a common cause of hydronephrosis in children. We aimed to investigate the efficacy of robotic-assisted laparoscopic pyeloplasty (RALP) in newborns with UPJO compared to laparoscopic pyeloplasty (LP). We conducted a retrospective study of newborns aged ≤ 3 months who underwent RALP or LP from May 2018 to December 2023. Only primary pyeloplasty cases were included. Seventy-seven newborns (RALP = 46; LP = 31) were enrolled and no significant difference in the newborns’ demographics and pre-operative parameters was found. The mean operation time (OT) was 161.30 ± 29.07 min (RALP) and 200.60 ± 26.66 min (LP) (P < 0.0001), and the mean hospitalization stay was 7.80 ± 1.13 days (RALP) and 9.32 ± 1.19 days (LP) (P < 0.0001). RALP was associated with a higher hospitalization cost than LP (73449 ± 8513 yuan vs. 40152 ± 7555 yuan; P < 0.0001). The effectiveness and safety of RALP for treating UPJO in newborns is comparable to that of LP. In addition, RALP might have advantages over LP with its faster recovery and less trauma.